Indications and Usage: Adequan^® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. The active ingredient in Adequan^® Canine is polysulfated glycosaminoglycan (PSGAG). Each mL of Adequan^® Canine contains 100 mg of PSGAG.

Dosage and Administration: The recommended dose of Adequan^® Canine is 2 mg/lb body weight (.02 mL/lb, or 1 mL per 50 lb), by intramuscular injection only, twice weekly for up to 4 weeks (maximum of 8 injections).

5ml vials